Private: Gallery Post #1

11

Jul2023

CADTH Announces Changes to Reimbursement Reviews Process & Fee Schedule Update

On June 5, 2023, the Canadian Agency for Drugs and Technologies in Health (CADTH) announced a series of process improvements it plans to explore or add to its drug reimbursement review process. These changes - aimed at gaining efficiencies, reducing timelines and improving transparency – include:... Read More

11

Jul2023

PMPRB Launches Consultation on its Amendment to the Interim Guidance RE: New Medicines

On June 20, 2023, PMPRB published proposed amendments to the Interim Guidance relating to  New Medicines. PMPRB has invited stakeholders to comment on the approach before August 21, 2023 (60-day consultation). After stakeholder consultation, a new set of guidelines is anticipated to be finalized in 2024.... Read More

02

May2023

PDCI’s Webinar Series: Tips for Health Technology Assessment (HTA) Submissions: Plan your Trip, Pack your Bags and Leave on Time

Join us on May 31st @ 12 p.m. ET for our upcoming webinar entitled: Tips for Health Technology Assessment (HTA) Submissions: Plan your Trip, Pack your Bags and Leave on Time. Join PDCI HTA Experts Andrea Lau (Associate Director, HTA and Clinical Evaluation), Tuhin Maity (Associate ... Read More

01

May2023

Connect with PDCI Market Access at the CADTH Symposium in Ottawa, May 16-18, 2023

PDCI Market Access is proud to announce is participation as a Platinum Sponsor of the 2023 CADTH Symposium taking place in Ottawa on May16-18, 2023. Join PDCI’s Courtney Abunassar on May 17 at 1 p.m. during Oral Presentations 3 – Policy Issues for a ... Read More

23

Mar2023

Federal Government Allocates Up to $1.4 Billion to Improve Access to Drugs for Rare Diseases

On March 22, 2023, Federal Minister of Health Jean-Yves Duclos announced $1.5 billion in funding associated with the government’s long anticipated national rare disease strategy first announced in 2019.Most of the funding – up to $1.4 billion – which is to be allocated over the next three years, ... Read More

07

Mar2023

PDCI Continues to Grow its Health Economy Capabilities with the Addition of Eric & Nathalie

Eric Opoku has joined PDCI Market Access as a Health Economist and HTA Associate. In his role, he will assist with the development and review of health economics components of reimbursement submissions to HTA agencies in ... Read More

07

Mar2023

Mélanie Bourassa Forcier References “Dialogue of the Deaf” Between PMPRB and Industry Among Reasons for her Resignation from PMPRB

In the wake of media attention around recent high-profile resignations from PMPRB, Melanie Bourassa Forcier, former Acting Chairperson of the PMPRB who resigned in December, came forward to "rectify the facts” about her reasons for resigning this past weekend.In her 5-page letter dated March 3rd and published on ... Read More

01

Mar2023

INESSS Fee Schedule Update; Upcoming CADTH Consultation and Application Process Updates

INESSS has published its updated fee schedule for its scientific evaluation of drugs, stable blood products and technologies in the February 18, 2023 Gazette du Québec. Fees for all submission types have increased 6.44% as of January 1, 2023, bringing fees to: $63,791 for a new ... Read More

24

Feb2023

Doug Clark Resigns from PMPRB

On February 24, 2023, Doug Clark announced he is stepping down from his position as Executive Director of the PMPRB after almost a decade with PMPRB. Clark will continue to serve as a special advisor to the Board as he transitions to retirement from the federal public service. ... Read More

24

Feb2023

PMPRB Board Member Resigns

On February 23, 2023, Matthew Herder, a PMPRB Board Member since 2018, publicly announced his resignation from the PMPRB. He shared his resignation letter on his personal twitter page today. The letter, which he notes was submitted to Health Minister Jean-Yves Duclos on Monday, outlines his reasons for parting ways with ... Read More